BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12223955)

  • 1. [Ocular hypertension and glaucoma: the contribution of large studies to daily practice].
    Bron A
    J Fr Ophtalmol; 2002 Jun; 25(6):641-54. PubMed ID: 12223955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update on prospective glaucoma intervention studies].
    Arend KO; Redbrake C
    Klin Monbl Augenheilkd; 2005 Oct; 222(10):807-13. PubMed ID: 16240274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.
    Maier PC; Funk J; Schwarzer G; Antes G; Falck-Ytter YT
    BMJ; 2005 Jul; 331(7509):134. PubMed ID: 15994659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?
    Parrish RK
    Curr Opin Ophthalmol; 2006 Apr; 17(2):138-41. PubMed ID: 16552248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial management of ocular hypertension and primary open-angle glaucoma: an evaluation of the royal college of ophthalmologists' guidelines.
    Choong YF; Devarajan N; Pickering A; Pickering S; Austin MW
    Eye (Lond); 2003 Aug; 17(6):685-90. PubMed ID: 12928677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating corneal pachymetry into the management of glaucoma.
    Iester M; Mete M; Figus M; Frezzotti P
    J Cataract Refract Surg; 2009 Sep; 35(9):1623-8. PubMed ID: 19683164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
    Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
    J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results after selective laser trabeculoplasty -- a clinical study on 269 eyes].
    Best UP; Domack H; Schmidt V
    Klin Monbl Augenheilkd; 2005 Apr; 222(4):326-31. PubMed ID: 15844043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of risk calculation on treatment recommendations made by glaucoma specialists in cases of ocular hypertension.
    Boland MV; Quigley HA; Lehmann HP
    J Glaucoma; 2008 Dec; 17(8):631-8. PubMed ID: 19092458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
    Best UP; Domack H; Schmidt V
    Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The probability of glaucoma from ocular hypertension determined by ophthalmologists in comparison to a risk calculator.
    Mansberger SL; Cioffi GA
    J Glaucoma; 2006 Oct; 15(5):426-31. PubMed ID: 16988606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalance of open angle glaucoma and ocular hypertension as a risk factor for primary open angle glaucoma in Wroclaw population. Wroclaw Epidemiology Study].
    Nizankowska MH; Kaczmarek R
    Klin Oczna; 2004; 106(1-2 Suppl):147-52. PubMed ID: 15510479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the European Glaucoma Prevention Study.
    Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
    Katz LJ; Simmons ST; Craven ER
    Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
    Miglior S; Torri V; Zeyen T; Pfeiffer N; Vaz JC; Adamsons I;
    Am J Ophthalmol; 2007 Aug; 144(2):266-275. PubMed ID: 17543874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.